Home
About
Overview
Sharing Data
ORCID
Help
History (19)
OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma.
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study.
Deoxyribonucleotides
Tunisia
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst. 1997 Jan 15; 89(2):158-65.
View in:
PubMed
subject areas
Adenocarcinoma
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Disease Progression
Disease-Free Survival
Flutamide
Gene Expression Regulation, Neoplastic
Genes, p53
Goserelin
Humans
Male
Middle Aged
Mutation
Prognosis
Prostatic Neoplasms
Radiotherapy, Adjuvant
Survival Analysis
Tumor Suppressor Protein p53